Work

CARs in Chronic Lymphocytic Leukemia – Ready to Drive

Year: 2012

Type: review

Source: Current Hematologic Malignancy Reports

DOI: 10.1007/s11899-012-0145-y

Authors: Chitra Hosing, Partow Kebriaei, William Wierda, Bipulendu Jena, Laurence J. N. Cooper, Elizabeth Shpall

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, National Institutes of Health, National Cancer Institute

Awards: G1619438925, Rebuilding Immunity for Survival, T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia, Rebuilding Immunity for Survival, UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY, G5756330340, Enhancing the efficacy of CD19-specific cord blood-derived T Cells, Adoptive immunotherapy after umbilical cord blood transplant, Chronic Lymphocytic Leukemia Research Consortium, UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY, Cancer Center Support Grant, G944802235

OpenAlex ID: W1995337370

FWCI: 0.23

Cites: 101

Cited by: 18

Related to: 10